Vanguard Group Inc - Sep 30, 2025 SCHEDULE 13G/A Report for Nektar Therapeutics Common Stock (NKTR)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Nektar Therapeutics Common Stock
Symbol: NKTR
Shares outstanding: 19M shares
Disclosed Ownership: 949K shares
Ownership: 4.98%
Form type: SCHEDULE 13G/A
Date filed: 10/31/2025, 11:05 AM
Date of event: Sep 30, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	4.98%	949K	0	107K	Ashley Grim	Head of Global Fund Administration